Akash Kedia, Managing Director – Healthcare and Lifesciences, Alvarez & Marsal India, and Amit Misra, Managing Director – Healthcare and Lifesciences, Alvarez & Marsal India, share their insights on the transformative trends shaping the Indian pharmaceutical landscape.
In an exclusive interview with Express Pharma, they provide expert insights on:
- CDMO valuations and their evolving significance
- Strategies to navigate regulatory challenges
- Global trade realignments and their impact
- The sector’s shift towards innovation and frontier market opportunities
- Unlocking the next levers of value creation
Read the full interview here
This article is an Intellectual Property of Express Pharma
OPTIONS TO SUPPORT VIABILITY FOR AUSTRALIA’S PRIVATE HOSPITAL SYSTEM
July 3, 2025
The Australian healthcare system has long been recognised as a global leader, balancing public, and private care to deliver exceptional outcomes for patients.This paper outlines a pathway to safeguard the future of Australia’s private hospital network
A&M continues to grow Private Equity Performance Improvement business in Europe
June 26, 2025
David Pérez joins to expand the firm’s commercial due diligence capabilities, deepen healthcare sector expertise and bolster the Nordic footprint.
Impending Medicaid Funding Reductions — Strategic Implications for Health Plans
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
Disruption in the ACA Market – Implications and Strategic Responses
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
